$PLL
Piedmont Lithium Inc.

2021 Q4 Form 10-Q Financial Statement

#000172820521000035 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $11.64M $9.345M
YoY Change 159.72%
% of Gross Profit
Research & Development $8.941M $10.38M
YoY Change 251.3%
% of Gross Profit
Depreciation & Amortization $8.700K $3.733K $1.376K
YoY Change -11.87% -89.62%
% of Gross Profit
Operating Expenses $20.58M $10.38M $19.74M
YoY Change 200.58%
Operating Profit -$10.38M -$7.479M
YoY Change 462.49%
Interest Expense -$121.4K -$59.05K -$63.22K
YoY Change 4.35% -109.2%
% of Operating Profit
Other Income/Expense, Net -$69.15K
YoY Change
Pretax Income -$20.71M -$10.50M -$7.600M
YoY Change 452.63% 29.27%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$21.35M -$10.86M -$7.633M
YoY Change 476.73% 29.83%
Net Earnings / Revenue
Basic Earnings Per Share -$0.68 -$0.48
Diluted Earnings Per Share -$1.345M -$0.68 -$0.48
COMMON SHARES
Basic Shares Outstanding 15.87M shares 15.86M shares 15.75M shares
Diluted Shares Outstanding 15.86M shares 15.75M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $64.76M $142.7M
YoY Change 656.49%
Cash & Equivalents $64.24M $81.95M $142.7M
Short-Term Investments $513.5K
Other Short-Term Assets $2.515M $2.469M $1.251M
YoY Change 2021.6%
Inventory
Prepaid Expenses $2.001M
Receivables
Other Receivables
Total Short-Term Assets $66.76M $84.42M $143.9M
YoY Change 660.74%
LONG-TERM ASSETS
Property, Plant & Equipment $40.06M $746.1K $725.9K
YoY Change 1.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $58.87M $58.54M $16.26M
YoY Change
Other Assets $4.561M $206.6K $222.7K
YoY Change 644.66%
Total Long-Term Assets $103.5M $95.62M $43.95M
YoY Change 403.02%
TOTAL ASSETS
Total Short-Term Assets $66.76M $84.42M $143.9M
Total Long-Term Assets $103.5M $95.62M $43.95M
Total Assets $170.2M $180.0M $187.9M
YoY Change 579.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.263M $2.833M $2.562M
YoY Change 223.77%
Accrued Expenses $5.425M $3.667M $2.397M
YoY Change 443.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $762.2K $1.287M $1.085M
YoY Change 87.88%
Total Short-Term Liabilities $7.550M $7.928M $6.215M
YoY Change 219.34%
LONG-TERM LIABILITIES
Long-Term Debt $914.1K $1.072M $1.226M
YoY Change -29.52%
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $914.1K $1.072M $1.226M
YoY Change -30.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.550M $7.928M $6.215M
Total Long-Term Liabilities $914.1K $1.072M $1.226M
Total Liabilities $8.464M $9.000M $7.441M
YoY Change 93.29%
SHAREHOLDERS EQUITY
Retained Earnings -$92.70M -$82.20M -$71.30M
YoY Change 38.21%
Common Stock $1.589K $1.560K $1.550K
YoY Change 51.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $161.8M $171.0M $180.4M
YoY Change
Total Liabilities & Shareholders Equity $170.2M $180.0M $187.9M
YoY Change 579.32%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021 Q2
OPERATING ACTIVITIES
Net Income -$21.35M -$10.86M -$7.633M
YoY Change 476.73% 29.83%
Depreciation, Depletion And Amortization $8.700K $3.733K $1.376K
YoY Change -11.87% -89.62%
Cash From Operating Activities -$17.67M -$9.265M -$16.26M
YoY Change 441.76% 156.74%
INVESTING ACTIVITIES
Capital Expenditures -$12.50M $23.99K -$18.21M
YoY Change 957.47% 427.41%
Acquisitions
YoY Change
Other Investing Activities -$47.91M -$16.36M
YoY Change
Cash From Investing Activities -$60.41M -$51.80M -$34.57M
YoY Change 1489.39% 901.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $192.8K
YoY Change 29.1%
Cash From Financing Activities -319.1K $364.3K 174.6M
YoY Change -95.17% 606.42%
NET CHANGE
Cash From Operating Activities -17.67M -$9.265M -16.26M
Cash From Investing Activities -60.41M -$51.80M -34.57M
Cash From Financing Activities -319.1K $364.3K 174.6M
Net Change In Cash -78.41M -$60.70M 123.8M
YoY Change -2460.16% 728.94%
FREE CASH FLOW
Cash From Operating Activities -$17.67M -$9.265M -$16.26M
Capital Expenditures -$12.50M $23.99K -$18.21M
Free Cash Flow -$5.175M -$9.289M $1.950M
YoY Change 442.44% -167.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Amendment Flag
AmendmentFlag
false
CY2021Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2021Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001728205
CY2021Q2 pll Chess Depository Interests Exchange Ratio
ChessDepositoryInterestsExchangeRatio
0.01
CY2021Q3 dei Document Type
DocumentType
10-Q
CY2021Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q3 dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
CY2021Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q3 dei Entity File Number
EntityFileNumber
001-38427
CY2021Q3 dei Entity Registrant Name
EntityRegistrantName
PIEDMONT LITHIUM INC.
CY2021Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4996461
CY2021Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
32 North Main Street
CY2021Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2021Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Belmont
CY2021Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2021Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
28012
CY2021Q3 dei City Area Code
CityAreaCode
704
CY2021Q3 dei Local Phone Number
LocalPhoneNumber
461-8000
CY2021Q3 dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
CY2021Q3 dei Trading Symbol
TradingSymbol
PLL
CY2021Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q3 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q3 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15869395 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81953152 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142651648 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2468945 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1251322 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
84422097 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
143902970 USD
CY2021Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
36030540 USD
CY2021Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
26597803 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
746124 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
725863 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
100862 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
139797 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
206561 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
222698 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
58539329 USD
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
16262498 USD
CY2021Q3 us-gaap Assets
Assets
180045513 USD
CY2021Q2 us-gaap Assets
Assets
187851629 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2832978 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2561834 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3666928 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2397197 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1287318 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1085142 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
100437 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
140435 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
40157 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
29906 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7927818 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6214514 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1072471 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1226404 USD
CY2021Q3 us-gaap Liabilities
Liabilities
9000289 USD
CY2021Q2 us-gaap Liabilities
Liabilities
7440918 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15869395 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15869395 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15764533 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15764533 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
1560 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1550 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
253962258 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
252571659 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82196004 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71334645 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-722590 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1883260 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-827853 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
171045224 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
180410711 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
180045513 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
187851629 USD
CY2021Q3 us-gaap Exploration Expense
ExplorationExpense
5563028 USD
CY2020Q3 us-gaap Exploration Expense
ExplorationExpense
1113675 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4818647 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
731973 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10381675 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1845648 USD
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-59051 USD
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-56589 USD
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10095 USD
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
18977 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10450821 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-410538 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10861359 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1883260 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15863027 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15863027 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11086970 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11086970 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10861359 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1883260 USD
CY2021Q3 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
105263 USD
CY2020Q3 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
0 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
105263 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10756096 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1883260 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10861359 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1883260 USD
CY2021Q3 us-gaap Depreciation
Depreciation
3733 USD
CY2020Q3 us-gaap Depreciation
Depreciation
4236 USD
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
833509 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
136466 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
38935 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
32643 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-410538 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1201486 USD
CY2020Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
34544 USD
CY2021Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-39998 USD
CY2020Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-32537 USD
CY2021Q3 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
271144 USD
CY2020Q3 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-254178 USD
CY2021Q3 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1279982 USD
CY2020Q3 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
321003 USD
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9265002 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1710171 USD
CY2021Q3 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
9191735 USD
CY2020Q3 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
3256708 USD
CY2021Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23994 USD
CY2020Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2269 USD
CY2021Q3 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
42582106 USD
CY2020Q3 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51797835 USD
CY2021Q3 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
241002 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3258977 USD
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7690251 USD
CY2021Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
557100 USD
CY2020Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2021Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
192759 USD
CY2020Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
149310 USD
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
364341 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7540941 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-60698496 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2571793 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142651648 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18857088 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81953152 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21428881 USD
CY2021Q3 us-gaap Interest Paid Net
InterestPaidNet
59051 USD
CY2020Q3 us-gaap Interest Paid Net
InterestPaidNet
65946 USD
CY2020Q3 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
389500 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
23803296 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7690251 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
136466 USD
CY2020Q3 pll Adjustments To Additional Paid In Capital Expiration Of Stock Options
AdjustmentsToAdditionalPaidInCapitalExpirationOfStockOptions
0 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1883260 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
29746753 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
180410711 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
833509 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
557100 USD
CY2021Q3 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
105263 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10861359 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
171045224 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82200000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71300000 USD
CY2021Q3 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets, fair value of stock-based compensation, income tax uncertainties, contingent assets and liabilities, legal claims, and environmental remediation. Actual results could differ due to the uncertainty inherent in the nature of these estimates.</span></div>
CY2021Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
36030540 USD
CY2021Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
26597803 USD
CY2021Q3 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
241002 USD
CY2020Q3 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
389500 USD
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
784926 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
760932 USD
CY2021Q3 us-gaap Depreciation
Depreciation
3733 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38802 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35069 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
746124 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
725863 USD
CY2020Q3 us-gaap Depreciation
Depreciation
4236 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
16262498 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-410538 USD
CY2021Q3 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
105263 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
58539329 USD
CY2021Q3 pll American Depositary Shares Conversion Ratio
AmericanDepositarySharesConversionRatio
100
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15764533 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 pll Sale Of Stock Offering Capacity
SaleOfStockOfferingCapacity
500000000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
833509 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
136466 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2800778 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
392504 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.16
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
536250 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.88
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.38
CY2021Q3 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised And Surrendered In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedAndSurrenderedInPeriod
120000 shares
CY2021Q3 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised And Surrendered In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedAndSurrenderedInPeriodWeightedAverageExercisePrice
13.93
CY2020Q3 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised And Surrendered In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedAndSurrenderedInPeriod
0 shares
CY2020Q3 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised And Surrendered In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedAndSurrenderedInPeriodWeightedAverageExercisePrice
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
60000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.13
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
272504 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
24.34
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
506250 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.65
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
571250 shares
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10861359 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10861359 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1883260 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1883260 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15863027 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15863027 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11086970 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11086970 shares
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
369249 shares
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10500000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1900000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0

Files In Submission

Name View Source Status
0001728205-21-000035-index-headers.html Edgar Link pending
0001728205-21-000035-index.html Edgar Link pending
0001728205-21-000035.txt Edgar Link pending
0001728205-21-000035-xbrl.zip Edgar Link pending
a231-qualifiedpersonll.htm Edgar Link pending
a232qualifiedpersonlm.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
plitrsfor211020mreupdate.htm Edgar Link pending
plitrsfor211020mreupdate001.jpg Edgar Link pending
plitrsfor211020mreupdate002.jpg Edgar Link pending
plitrsfor211020mreupdate003.jpg Edgar Link pending
plitrsfor211020mreupdate004.jpg Edgar Link pending
plitrsfor211020mreupdate005.jpg Edgar Link pending
plitrsfor211020mreupdate006.jpg Edgar Link pending
plitrsfor211020mreupdate007.jpg Edgar Link pending
plitrsfor211020mreupdate008.jpg Edgar Link pending
plitrsfor211020mreupdate009.jpg Edgar Link pending
plitrsfor211020mreupdate010.jpg Edgar Link pending
plitrsfor211020mreupdate011.jpg Edgar Link pending
plitrsfor211020mreupdate012.jpg Edgar Link pending
plitrsfor211020mreupdate013.jpg Edgar Link pending
plitrsfor211020mreupdate014.jpg Edgar Link pending
plitrsfor211020mreupdate015.jpg Edgar Link pending
plitrsfor211020mreupdate016.jpg Edgar Link pending
plitrsfor211020mreupdate017.jpg Edgar Link pending
plitrsfor211020mreupdate018.jpg Edgar Link pending
plitrsfor211020mreupdate019.jpg Edgar Link pending
plitrsfor211020mreupdate020.jpg Edgar Link pending
plitrsfor211020mreupdate021.jpg Edgar Link pending
plitrsfor211020mreupdate022.jpg Edgar Link pending
plitrsfor211020mreupdate023.jpg Edgar Link pending
plitrsfor211020mreupdate024.jpg Edgar Link pending
plitrsfor211020mreupdate025.jpg Edgar Link pending
plitrsfor211020mreupdate026.jpg Edgar Link pending
plitrsfor211020mreupdate027.jpg Edgar Link pending
plitrsfor211020mreupdate028.jpg Edgar Link pending
plitrsfor211020mreupdate029.jpg Edgar Link pending
plitrsfor211020mreupdate030.jpg Edgar Link pending
plitrsfor211020mreupdate031.jpg Edgar Link pending
plitrsfor211020mreupdate032.jpg Edgar Link pending
plitrsfor211020mreupdate033.jpg Edgar Link pending
plitrsfor211020mreupdate034.jpg Edgar Link pending
plitrsfor211020mreupdate035.jpg Edgar Link pending
plitrsfor211020mreupdate036.jpg Edgar Link pending
plitrsfor211020mreupdate037.jpg Edgar Link pending
plitrsfor211020mreupdate038.jpg Edgar Link pending
plitrsfor211020mreupdate039.jpg Edgar Link pending
plitrsfor211020mreupdate040.jpg Edgar Link pending
plitrsfor211020mreupdate041.jpg Edgar Link pending
plitrsfor211020mreupdate042.jpg Edgar Link pending
plitrsfor211020mreupdate043.jpg Edgar Link pending
plitrsfor211020mreupdate044.jpg Edgar Link pending
plitrsfor211020mreupdate045.jpg Edgar Link pending
plitrsfor211020mreupdate046.jpg Edgar Link pending
plitrsfor211020mreupdate047.jpg Edgar Link pending
plitrsfor211020mreupdate048.jpg Edgar Link pending
plitrsfor211020mreupdate049.jpg Edgar Link pending
plitrsfor211020mreupdate050.jpg Edgar Link pending
plitrsfor211020mreupdate051.jpg Edgar Link pending
plitrsfor211020mreupdate052.jpg Edgar Link pending
plitrsfor211020mreupdate053.jpg Edgar Link pending
plitrsfor211020mreupdate054.jpg Edgar Link pending
plitrsfor211020mreupdate055.jpg Edgar Link pending
plitrsfor211020mreupdate056.jpg Edgar Link pending
plitrsfor211020mreupdate057.jpg Edgar Link pending
plitrsfor211020mreupdate058.jpg Edgar Link pending
plitrsfor211020mreupdate059.jpg Edgar Link pending
plitrsfor211020mreupdate060.jpg Edgar Link pending
plitrsfor211020mreupdate061.jpg Edgar Link pending
plitrsfor211020mreupdate062.jpg Edgar Link pending
plitrsfor211020mreupdate063.jpg Edgar Link pending
plitrsfor211020mreupdate064.jpg Edgar Link pending
plitrsfor211020mreupdate065.jpg Edgar Link pending
plitrsfor211020mreupdate066.jpg Edgar Link pending
plitrsfor211020mreupdate067.jpg Edgar Link pending
plitrsfor211020mreupdate068.jpg Edgar Link pending
plitrsfor211020mreupdate069.jpg Edgar Link pending
plitrsfor211020mreupdate070.jpg Edgar Link pending
plitrsfor211020mreupdate071.jpg Edgar Link pending
plitrsfor211020mreupdate072.jpg Edgar Link pending
plitrsfor211020mreupdate073.jpg Edgar Link pending
plitrsfor211020mreupdate074.jpg Edgar Link pending
plitrsfor211020mreupdate075.jpg Edgar Link pending
plitrsfor211020mreupdate076.jpg Edgar Link pending
plitrsfor211020mreupdate077.jpg Edgar Link pending
plitrsfor211020mreupdate078.jpg Edgar Link pending
plitrsfor211020mreupdate079.jpg Edgar Link pending
plitrsfor211020mreupdate080.jpg Edgar Link pending
plitrsfor211020mreupdate081.jpg Edgar Link pending
plitrsfor211020mreupdate082.jpg Edgar Link pending
plitrsfor211020mreupdate083.jpg Edgar Link pending
plitrsfor211020mreupdate084.jpg Edgar Link pending
plitrsfor211020mreupdate085.jpg Edgar Link pending
pll-20210630xex3111.htm Edgar Link pending
pll-20210630xex3121.htm Edgar Link pending
pll-20210630xex3211.htm Edgar Link pending
pll-20210630xex3221.htm Edgar Link pending
pll-20210930.htm Edgar Link pending
pll-20210930.xsd Edgar Link pending
pll-20210930_cal.xml Edgar Link unprocessable
pll-20210930_def.xml Edgar Link unprocessable
pll-20210930_htm.xml Edgar Link completed
pll-20210930_lab.xml Edgar Link unprocessable
pll-20210930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending